Aoxing Pharmaceutical Company Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Zhenjiang Yue

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	19yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	16.2yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Zhenjiang Yue (65 yo)

19yrs

Tenure

US$155,316

Compensation

Mr. Zhenjiang Yue serves as the Chairman and Chief Executive Officer at Aoxing Pharmaceutical Company, Inc. Mr. Yue established the Hebei Aoxing Group in 2000 and has been its President and its General Man...

Board Members

Name	Position	Tenure	Compensation	Ownership
Zhenjiang Yue	Chairman and Chief Executive Officer	19yrs	US$155.32k	no data
Jun Min	Director	16.2yrs	no data	no data
Guozhu Xu	Independent Director	16.2yrs	US$15.52k	no data
Yang Li	Independent Director	12.7yrs	US$15.52k	no data
Yuelin Zhang	Independent Director	8.6yrs	no data	no data

16.2yrs

Average Tenure

65yo

Average Age

Experienced Board: AOXG's board of directors are seasoned and experienced ( 16.2 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/12 05:59
End of Day Share Price	2025/01/10 00:00
Earnings	2017/03/31
Annual Earnings	2016/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aoxing Pharmaceutical Company, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Elemer Piros	Rodman & Renshaw, LLC